News of Note—Prevnar 13, leprosy vaccine and more

In this week's news of note, MSF is challenging a Prevnar 13 patent.

Here is some other vaccine news of note for this week.

> Médecins Sans Frontières is moving to block Pfizer's new Prevnar 13 patent in India. Release

> The Infectious Disease Research Institute and American Leprosy Missions started a phase 1 study for the first vaccine specifically targeting leprosy. Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.

> CSL, which owns flu vaccine player Seqirus, changed its executive pay policies. Sydney Morning Herald story

Read more on